Skip to main content
PL

Pagari Life Science

Pagari Life Science develops anti-herpetic and healing drugs that utilize targeted viral deactivation and pain control mechanisms through safe, non-addictive therapeutics. Their products, including Helocaine for cold sores and minor burns, provide effective treatment options for conditions such as genital herpes, shingles, and post-herpetic neuralgia.

Bethalto, United StatesFounded 20223200+ followers
Updated 4 months ago

Funding

$530K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Current treatments for herpes simplex virus (HSV) and herpes zoster virus (HZV) infections, such as cold sores, genital herpes, and shingles, often have limited efficacy and can cause side effects. Existing pain management options for conditions like post-herpetic neuralgia may be inadequate or carry a risk of addiction.

Solution

Pagari Life Science is developing a new class of anti-herpetic and advanced healing drugs designed to target viral deactivation, promote healing, and control pain. Their therapeutics aim to provide effective treatment options for conditions caused by HSV and HZV, as well as minor burns and wounds, using safe and non-addictive mechanisms. The company's approach focuses on addressing the underlying viral infection while simultaneously managing associated pain and promoting tissue repair.

Target Audience

The primary target audience includes individuals suffering from herpes simplex virus (HSV) infections (cold sores, genital herpes), herpes zoster virus (HZV) infections (shingles, post-herpetic neuralgia), as well as those seeking treatment for minor burns and wounds.

Features

  • Targeted viral deactivation to reduce viral load and prevent further spread
  • Pain control mechanisms to alleviate discomfort associated with herpes outbreaks and nerve damage
  • Advanced healing properties to accelerate tissue repair and reduce scarring
  • Non-addictive therapeutics to minimize the risk of dependence and adverse effects
  • Topical formulations for localized treatment of cold sores, genital herpes, shingles, minor burns, and wounds
This profile is AI-generated and may contain inaccuracies.